Antinuclear antibodies in patients receiving non-practolol beta-blockers.

7 January 1978

journal article
research article
Published by BMJ in BMJ

Vol. 1 (6104) , 14-16
https://doi.org/10.1136/bmj.1.6104.14

Abstract

Antinuclear antibodies (ANA) were found in 54 (7.0%) out of 767 treated hypertensive patients compared with 59 (2.4%) out of 2470 healthy controls. Inclusion of a non-practolol beta-blocker in the treatment regimen did not significantly affect the incidence of ANA. ANA was found in significantly more patients being treated with methyldopa (13.0%) than patients receiving other hypotensive agents (3.8%). Non-practolol beta-blockers in combination with methyldopa did not increase the incidence of ANA further.

Keywords

ANTINUCLEAR
ANA
TREATMENT
ANTIBODIES
PATIENTS RECEIVING
PRACTOLOL BETA BLOCKERS

This publication has 3 references indexed in Scilit:

Untoward effects associated with practolol: demonstration of antibody binding to epithelial tissue.
BMJ, 1975
Untoward effects associated with practolol administration: oculomucocutaneous syndrome.
BMJ, 1975
POSITIVE DIRECT COOMBS TESTS AND ANTINUCLEAR FACTOR IN PATIENTS TREATED WITH METHYLDOPA
The Lancet, 1967